Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTPN1 | P18031 | 2/20 | 0.45 |
| ▸ | CALM1 | P0DP23 | 1/20 | 0.44 |
| ▸ | TSHR | P16473 | 2/20 | 0.44 |
| ▸ | HTR2A | P28223 | 1/20 | 0.44 |
| ▸ | NR3C1 | P04150 | 8/20 | 0.43 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.42 |
| ▸ | BCL2 | P10415 | 1/20 | 0.42 |
| ▸ | BCL2L1 | Q07817 | 1/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.41 |
| ▸ | PGR | P06401 | 1/20 | 0.41 |
| ▸ | NR3C2 | P08235 | 1/20 | 0.41 |
| ▸ | AR | P10275 | 1/20 | 0.41 |
| ▸ | AOC3 | Q16853 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11523001 | 0.94 | TSHR (0.45) | PTPN1CALM1TSHRNR3C1CYP2C19 | |
| SCHEMBL18050878 | 0.87 | HTR2A (0.42) | PTPN1CALM1TSHRHTR2ANR3C1 | |
| SCHEMBL7148219 | 0.82 | TSHR (0.54) | CALM1TSHRNR3C1CYP2C19ALDH1A1 | |
| SCHEMBL8364929 | 0.82 | AR (0.48) | PTPN1CALM1TSHRHTR2ACYP2C19 | |
| SCHEMBL10659836 | 0.80 | BCL2 (0.52) | PTPN1CALM1HTR2ABCL2BCL2L1 | |
| SCHEMBL4058078 | 0.79 | PTPN1 (0.42) | PTPN1CALM1TSHRHTR2ABCL2 | |
| Bromide SCHEMBL10963850 | 0.77 | DRD2 (0.46) | PTPN1CALM1TSHRHTR2ABCL2 | |
| SCHEMBL1024641 | 0.77 | TDP1 (0.51) | PTPN1TSHRHTR2ABCL2BCL2L1 | |
| SCHEMBL3006766 | 0.77 | TRPM8 (0.54) | TSHRNR3C1CYP2C19ALDH1A1PGR | |
| SCHEMBL29878136 | 0.77 | PTPN1 (0.47) | PTPN1CALM1TSHRHTR2ABCL2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2039698-B1 | PHOSPHORUS MOLYBDENUM COMPOUND AND METHOD FOR PRODUCING THE SAME | ADEKA CORP (JP) | 2013-04-17 | — | — | EP | disclosed |
| EP-2078725-B1 | PHOSPHORUS-MOLYBDENUM COMPOUND, METHOD FOR PRODUCING THE SAME, LUBRICANT ADDITIVE CONTAINING THE COMPOUND, AND LUBRICANT COMPOSITION | ADEKA CORP (JP) | 2012-04-18 | — | — | EP | disclosed |
| US-8071801-B2 | Phosphorus molybdenum compound and method for producing same | ADEKA CORPORATION (JP) | 2011-12-06 | — | — | US | disclosed |
| US-8012916-B2 | Phosphorus-molybdenum compound, method for producing same and lubricant additive and lubricant composition containing the compound | ADEKA CORPORATION (JP) | 2011-09-06 | — | — | US | disclosed |
| US-20090270289-A1 | Phosphorus-molybdenum compound, method for producing same and lubricant additive and lubricant composition containing the compound | ADEKA CORPORATION (JP) | 2009-10-29 | — | — | US | disclosed |
| US-20090192062-A1 | Phosphorus molybdenum compound and method for producing same | ADEKA CORPORATION (JP) | 2009-07-30 | — | — | US | disclosed |
| EP-2078725-A1 | PHOSPHORUS-MOLYBDENUM COMPOUND, METHOD FOR PRODUCING THE SAME, LUBRICANT ADDITIVE CONTAINING THE COMPOUND, AND LUBRICANT COMPOSITION | Adeka Corporation (JP) | 2009-07-15 | — | — | EP | disclosed |
| EP-2039698-A1 | PHOSPHORUS MOLYBDENUM COMPOUND AND METHOD FOR PRODUCING THE SAME | Adeka Corporation (JP) | 2009-03-25 | — | — | EP | disclosed |
| CN-101218546-A | Pattern forming method | FUJIFILM CORP (JP) | 2008-07-09 | — | — | CN | disclosed |
| US-20070155636-A1 | Lubricating oil additive and lubricating oil composition containing the same | ADEKA CORPORATION (JP) | 2007-07-05 | — | — | US | disclosed |
| EP-1717298-A1 | LUBRICATING OIL ADDITIVE AND LUBRICATING OIL COMPOSITION CONTAINING SAME | Adeka Corporation (JP) | 2006-11-02 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090270289-A1 | Phosphorus-molybdenum compound, method for producing same and lubricant additive and lubricant composition containing the compound | JAK1, PRDX1, PRDX4 | PTPN1 2903/4885CALM1 3273/4885TSHR 3839/4885 |
| US-20090192062-A1 | Phosphorus molybdenum compound and method for producing same | PHPT1, PHOSPHO1, MPHOSPH6 | PTPN1 765/4885CALM1 3440/4885TSHR 1088/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.